Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03551171
What this trial is testing

The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 42
Large-scale testing (Phase 3)Study completedNCT02580058
What this trial is testing

Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

Who this might be right for
Ovarian Cancer
Pfizer 566
Testing effectiveness (Phase 2)Looking for participantsNCT07050771
What this trial is testing

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Who this might be right for
Hepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more
The Methodist Hospital Research Institute 148
Post-approval studies (Phase 4)Active Not RecruitingNCT05206448
What this trial is testing

Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation

Who this might be right for
Polycystic Ovary SyndromePCOSInfertility
Rachel Mejia 190
Not applicableUnknownNCT03877185
What this trial is testing

A New Revolutionary 3-Injection- Protocol in Infertile Women

Who this might be right for
Infertility, Female
Assisting Nature 100
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Testing effectiveness (Phase 2)Study completedNCT03628716
What this trial is testing

CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Who this might be right for
Bladder Cancer
Bavarian Nordic 43
Large-scale testing (Phase 3)Study completedNCT06720233
What this trial is testing

Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis

Who this might be right for
Anemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 37
Early research (Phase 1)Study completedNCT02022748
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects

Who this might be right for
Kidney Failure, Chronic
AstraZeneca 27
Early research (Phase 1)Study completedNCT02312973
What this trial is testing

To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects

Who this might be right for
Renal Insufficiency, Chronic
Bayer 40
Early research (Phase 1)Looking for participantsNCT05403554
What this trial is testing

NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Who this might be right for
Epithelial Ovarian CancerTriple Negative Breast CancerNon-squamous Non-small-cell Lung Cancer+2 more
Light Chain Bioscience - Novimmune SA 70
Early research (Phase 1)Study completedNCT01740362
What this trial is testing

Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function

Who this might be right for
Renal Impairment
Pfizer 24
Testing effectiveness (Phase 2)Study completedNCT00073541
What this trial is testing

The Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
EMD Serono 38
Testing effectiveness (Phase 2)Study completedNCT01248962
What this trial is testing

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 146
Early research (Phase 1)Study completedNCT04540705
What this trial is testing

Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 30
Testing effectiveness (Phase 2)Looking for participantsNCT06040970
What this trial is testing

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Ovarian CancerMalignant Neoplasm of Uterus
Icahn School of Medicine at Mount Sinai 54
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01090466
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02595892
What this trial is testing

Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian Serous TumorRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT04477265
What this trial is testing

Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder

Who this might be right for
Overactive Bladder
Far Eastern Memorial Hospital 140
Next Page